GRADIENT DENERVATION TECHNOLOGIES
Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.
GRADIENT DENERVATION TECHNOLOGIES
Industry:
Biotechnology Medical Device
Founded:
2019-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.gradientdenervation.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apple Mobile Web Clips Icon Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare JS
Similar Organizations
LEX Diagnostics
LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care.
Current Employees Featured
Investors List
MedTech Innovator
MedTech Innovator investment in Non Equity Assistance - Gradient Denervation Technologies
MD Start
MD Start investment in Seed Round - Gradient Denervation Technologies
Official Site Inspections
http://www.gradientdenervation.com
- Host name: cluster028.hosting.ovh.net
- IP address: 92.222.139.190
- Location: Paris France
- Latitude: 48.8607
- Longitude: 2.3281
- Timezone: Europe/Paris
- Postal: 75001
More informations about "Gradient Denervation Technologies"
Gradient Denervation Technologies - A new approach …
Gradient Denervation Technologies enrolls initial patient in first-in-human study of pulmonary artery denervation technology PARIS, FRANCE, JUNE 1, 2023 — Gradient Denervation Technologies, a Paris-based medical device company …See details»
Legal Notice - gradientdenervation.com
Website publisher: GRADIENT DENERVATION TECHNOLOGIES, a French simplified joint stock company Head office: 5, rue Gardenat Lapostol, 92150 Surenes (France) Registered capital: 8 …See details»
Gradient Denervation Technologies - Crunchbase
Gradient Denervation Technologies may be growing as it successfully secured €14M in a Series A funding round, which is a significant financial milestone for startups and often reflects confidence from investors in the company's …See details»
Gradient Denervation Technologies - PitchBook
Dec 7, 2020 Gradient Denervation Technologies General Information Description. Developer of a novel endovascular, catheter-based technology intended to perform pulmonary artery denervation with heart failure and …See details»
Gradient Denervation Technologies SAS - 药物管线_专利_临床试 …
The PreVail-PH2 study is enrolling patients with pulmonary hypertension due to left-sided heart disease, classified by the World Health Organization (WHO) as Group 2 Pulmonary …See details»
Gradient Denervation Technologies | LinkedIn
Gradient Denervation Technologies | 1,202 followers on LinkedIn. Transforming the treatment of pulmonary hypertension | A solution for patients suffering from heart failure with pulmonary ...See details»
Gradient Denervation Technologies Enrolls First Patient …
Mar 6, 2024 The PreVail-PH2 study is enrolling patients with pulmonary hypertension due to left-sided heart disease, classified by the World Health Organization (WHO) as Group 2 Pulmonary Hypertension.See details»
Gradient Denervation Technologies closes €14m Series A
Sep 7, 2023 www.gradientdenervation.com. About Asabys Partners Asabys Partners is a venture capital firm specialized in the healthcare sector, founded in 2018 by Josep Ll. Sanfeliu …See details»
Gradient Denervation Technologies Enrolls Initial …
Jun 1, 2023 Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive device for treating certain heart failure patients with associated pulmonary hypertension ...See details»
Gradient Denervation Technologies Enrolls First Patient …
The PreVail-PH2 study is enrolling patients with pulmonary hypertension due to left-sided heart disease, classified by the World Health Organization (WHO) as Group 2 Pulmonary Hypertension. As many as half of heart failure patients …See details»
Gradient Denervation Technologies closes €14m Series A led by …
Sep 10, 2023 www.gradientdenervation.com. About Asabys Partners Asabys Partners is a venture capital firm specialized in the healthcare sector, founded in 2018 by Josep Ll. Sanfeliu …See details»
Gradient Denervation Technologies Appoints Stanton Rowe to …
Oct 22, 2024 Serial entrepreneur and medical device industry executive adds key experience to board of directorsPARIS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gradient Denervation …See details»
Gradient Denervation Technologies — Sofinnova Partners
Sep 16, 2020 www.gradientdenervation.com. Mano Iyer. Partner, Sofinnova Partners - MD Start Strategy. Related News. 22 October, 2024 Gradient Denervation Technologies appoints …See details»
Gradient Denervation Technologies Enrolls Initial Patient in
Jun 1, 2023 Company plans Early Feasibility Study in the US for late 2023. PARIS, FRANCE / ACCESSWIRE / June 1, 2023 / Gradient Denervation Technologies, a Paris-based medical …See details»
Gradient Denervation Technologies - Products, Competitors, …
Gradient leverages intellectual property developed at Stanford University. The Gradient device is for investigational use only and is not approved for commercial use anywhere in the world. For …See details»
Gradient Denervation Technologies closes €14m Series A led
Www.gradientdenervation.com. About Asabys Partners. Asabys Partners is a venture capital firm specialized in the healthcare sector, founded in 2018 by Josep Ll. Sanfeliu and Clara Campàs, …See details»
Gradient Denervation Technologies Announces Appointment of …
Apr 7, 2022 PARIS, FRANCE / ACCESSWIRE / April 7, 2022 /Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive …See details»
Gradient Denervation Technologies Raises €3.5M in Seed Funding …
Sep 17, 2020 For more information, please visit: https://www.gradientdenervation.com About Sofinnova Partners Sofinnova Partners is a leading European venture capital firm specialized …See details»
Gradient Denervation Technologies Raises €3.5M in Seed
Sep 17, 2020 For more information, please visit: https://www.gradientdenervation.com. About Sofinnova Partners. Sofinnova Partners is a leading European venture capital firm specialized …See details»
Gradient Denervation Technologies appoints Stanton Rowe to …
Oct 22, 2024 Serial entrepreneur and medical device industry executive adds key experience to board of directors. PARIS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gradient Denervation …See details»